CORBUS PHARMACEUTICALS HOLDI (CRBP) Stock Balance Sheet
NASDAQ:CRBP - US21833P3010 - Common Stock
9.89 USD
+0.1 (+1.02%)
10.32 USD
+0.43 (+4.35%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 2.29M | 5.05M | 4.03M | 3.80M | 6.80M | |||
| Cash Equivalents | 17.75M | 12.15M | 9.70M | 13.20M | 18.30M | |||
| Marketable Securities | 96.55M | 131.86M | 7.18M | 42.20M | 72.60M | |||
| Receivables | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Current Assets | 6.23M | 3.91M | 2.64M | 1.00M | 2.60M | |||
| Total Current Assets | 122.83M | 152.98M | 23.55M | 60.20M | 100.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.88M | 2.52M | 4.04M | 5.50M | 7.00M | |||
| Other Non-Current Assets | 385.00K | 385.00K | 690.20K | 600.00K | 500.00K | |||
| Total Non-Current Assets | 2.26M | 2.90M | 4.73M | 6.10M | 7.50M | |||
| TOTAL ASSETS | 125.08M | 155.88M | 28.27M | 66.30M | 107.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 16.21M | 3.10M | 3.90M | |||
| Accrued Expenses | 9.35M | 7.03M | 12.47M | 7.30M | 11.20M | |||
| Accounts Payable | 3.99M | 4.79M | 3.18M | 2.20M | 1.80M | |||
| Other Current Liabilities | N/A | 0.00 | 39.50K | 0.00 | 100.00K | |||
| Total Current Liabilities | 13.33M | 11.82M | 31.89M | 12.60M | 17.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 16.00M | 15.60M | |||
| Other Non-Current Liabilities | 761.00K | 1.63M | 3.28M | 4.70M | 6.00M | |||
| Total Non-Current Liabilities | 761.00K | 1.63M | 3.28M | 20.70M | 21.60M | |||
| TOTAL LIABILITIES | 14.09M | 13.45M | 35.18M | 33.30M | 38.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -511.53M | -476.89M | -436.68M | -392.10M | -349.70M | |||
| Additional Paid In Capital | 622.56M | 619.28M | 429.78M | 425.20M | 418.90M | |||
| Common Shares | 1.00K | 1.00K | 400.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -39.00K | 35.00K | -1.60K | -100.00K | -100.00K | |||
| Shares Outstanding | 12.25M | 12.18M | 4.42M | 4.20M | 4.20M | |||
| Tangible Book Value per Share | 9.06 | 11.69 | -1.56 | 7.86 | 16.45 | |||
| Total Shareholders' Equity | 110.99M | 142.43M | -6.90M | 33.00M | 69.10M | |||
| TOTAL LIABILITIES AND EQUITY | 125.08M | 155.88M | 28.27M | 66.30M | 107.70M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.48 | 0.23 | |||
| Current Ratio | 9.21 | 12.94 | 0.74 | 4.78 | 5.89 | |||
| Return On Assets (ROA) | -46.33% | -25.66% | -159.17% | -63.88% | -42.38% | |||
| Return On Equity (ROE) | -52.21% | -28.08% | N/A | -128.33% | -66.05% | |||
All data in USD , ROIC based on taxRate of 0.21